A meta-review of evidence on heart failure disease management programs: The challenges of describing and synthesizing evidence on complex interventions

Trials

Volumn 12, Issue , 2011, Pages

  Savard, Lori A ^a   Thompson, David R ^b   Clark, Alexander M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HEART FAILURE; HUMAN; META ANALYSIS (TOPIC); OUTCOMES RESEARCH; QUALITY CONTROL; SYSTEMATIC REVIEW; AGED; FEMALE; HEALTH SERVICES RESEARCH; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT CARE; REVIEW; RISK; STANDARD; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES RESEARCH; HEART FAILURE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; ODDS RATIO; PATIENT CARE MANAGEMENT; PATIENT CARE TEAM; QUALITY CONTROL; TREATMENT OUTCOME;

EID: 80051640460     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-194     Document Type: Article

References (56)

1. Heart Failure Society of America HFSA 2006 Comprehensive Heart Failure Practice Guideline 2006, St Paul, Minnesota: HFSA, Heart Failure Society of America.
2. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel) Guidelines for the prevention, detection and management of chronic heart failure in Australia. 2006, National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel).
3. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:1977-2016.
4. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, et al. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. European Heart Journal 2008, 29:2388-2442. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology.
5. Jaarsma T, van der Wal M, Lesman-Leegte I, Luttik M, Hogenhuis J, Veeger N, Sanderman R, Hoes A, van Gilst W, Dirk JA, Lok M, et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure coordinating study evaluating outcomes of advising and counseling in heart failure (COACH). Archives of Internal Medicine 2008, 168:316-324. 10.1001/archinternmed.2007.83, 18268174.
6. Nucifora G, Albanese M, De Biaggio P, Caliandro D, Gregori D, Goss P, Miani D, Fresco C, Rossi P, Bulfoni AF, Fioretti PM. Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management programme. Journal of Cardiovascular Medicine 2006, 7:614-622. 10.2459/01.JCM.0000237910.34000.58, 16858241.
7. Smith B, Forkner EZB, Krasuski R, Stajduhar K, Kwan M, Ellis R, Galbreath A, Freeman G. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. American Journal of Managed Care 2005, 11:701-703.
8. Nguyen V, Ducharme A, White M, Racine N, O'Meara E, Zhang B, Rouleau JL, Brophy J. Lack of long-term benefits of a 6-month heart failure disease management program. Journal of Cardiac Failure 2006, 13:287-293.
9. Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. British Medical Journal 2007, 334:1098. 10.1136/bmj.39164.568183.AE, 1877883, 17452390.
10. Ledwidge M, Ryan E, O'Loughlin C, Ryder M, Travers B, Kieran E, Walsh A, McDonald K. Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs. European Journal of Heart Failure 2005, 16:385-391.
11. Jaarsma T, van Veldhuisen D. When, how and where should we "coach" patients with heart failure: The COACH results in perspective. European Journal of Heart Failure 2008, 10:331-333. 10.1016/j.ejheart.2008.02.017, 18353718.
12. Sochalski J, Jaarsma T, Krumholz HM, Laramee A, McMurray JJV, Naylor MD, Rich MW, Riegel B, Stewart S. What works in chronic care management: The case of heart failure. Health Affairs 2009, 28:179-189. 10.1377/hlthaff.28.1.179, 19124869.
13. Kapp M, MccCall N, Cromwell J, Urato C, Rabiner D. Evaluation of the phase I of the Medicare Health Support Pilot Program Under traditional fee-for-service medicare: 18 month interim analysis 2008, Batimore, MA: Centers for Medicare & Medicaid Services.
14. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis 2009, London: John Wiley.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, . the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Medicine 2009, 3:123-130. the PRISMA Group.
16. Glasgow RE, Emmons KM. How can we increase the translation of research into practice: Types of evidence needed. Annual Review of Public Health 2007, 28:413-433. 10.1146/annurev.publhealth.28.021406.144145, 17150029.
17. Guyatt G, Rennie D, Meade M, Cook D. User's guide to the medical literature 2008, NY, New York: American Medical Association.
18. Krumholz H, Currie P, Riegel B, Phillips CO, Peterson ED, Smith R, Yancy CW, Faxon DP. A taxonomy for disease management: A scientific statement from the American Heart Association Disease Management Taxononmy Writing Group. Circulation 2006, 114:1432-1445. 10.1161/CIRCULATIONAHA.106.177322, 16952985.
19. Whitlock E, Lin J, Chou R, Shekelle P, Robinson K. Using exisiting systematic reviews in complex systematic reviews. Annals of Internal Medicine 2008, 148:776-782.
20. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone J, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. American Journal of Medicine 2004, 116:682-692. 10.1016/j.amjmed.2004.01.009, 15121495.
21. Clark AM, Hartling L, Vandermeer B, McAlister FA. Secondary prevention program for patients with coronary artery disease: A meta-analysis of randomized control trials. Annals of Internal Medicine 2005, 143:659-672.
22. Shea B, Grimshaw J, Wells G, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter L. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007, 7(10).
23. Kim Y, Soeken KL. A meta-analysis of the effect of hospital-based case management on hospital length of stay and readmission. Nursing Research 2005, 54:255-264.
24. Jovicic A, Holroyd-Leduc JM, Straus SE. Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovascular Disorders 2006, 6:43. 10.1186/1471-2261-6-43, 1660572, 17081306.
25. Clark R, Inglis S, McAlister F, Cleland J, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. British Medical Journal 2007, 334:942. 10.1136/bmj.39156.536968.55, 1865411, 17426062.
26. McAlister F, Lawson FME, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. American Journal of Medicine 2001, 110:378-384. 10.1016/S0002-9343(00)00743-9, 11286953.
27. Taylor S, Bestall J, Cotter S, Falshaw M, Hood S, Parsons S, Wood L, Underwood M. Clinical service organization for heart failure. The Cochrane Library 2005, 3.
28. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients; a meta-analysis. European Journal of Heart Failure 2005, 7:1133-1144. 10.1016/j.ejheart.2005.08.005, 16198629.
29. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: A meta-analysis. Journal of the American Medical Association 2004, 291:1358-1367. 10.1001/jama.291.11.1358, 15026403.
30. McAlister F, Stewart S, Ferrua S, McMurray JJ. Multi-disciplinary strategies for the management of heart failure patients at high risk of admission: A systematic review of randomized trials. Journal of the American College of Cardiology 2004, 44:810-819.
31. Phillips CO, Singa RM, Rubin HR, Jaarsma T. Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis. European Journal of Heart Failure 2005, 7:333-341. 10.1016/j.ejheart.2005.01.011, 15718173.
32. Gohler A, Januzzi J, Worrell SS, Osterziel KJ, Scott G, Dietz R, Siebert U. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. Journal of Cardiac Failure 2006, 12:554-567. 10.1016/j.cardfail.2006.03.003, 16952790.
33. Gwadry-Sridhar FH, Flintoft V, Lee DS, Lee H, Guyatt GH. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Archives of Internal Medicine 2004, 164:2315-2320. 10.1001/archinte.164.21.2315, 15557409.
34. Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart 2005, 91:899-906. 10.1136/hrt.2004.048389, 1769009, 15958358.
35. Koshman S, Charrois T, Simpson S, McAlister F, Tsuyuki R. Pharmacist care of patients with heart failure: A systematic review of randomized trials. Archives of Internal Medicine 2008, 168:687-694. 10.1001/archinte.168.7.687, 18413550.
36. Whellan DJ, Hasselblad V, Peterson E, O'Conner C, Schulman K. Meta-analysis and review of heart failure disease management randomized controlled clinical trials. American Heart Journal 2005, 149:722-729. 10.1016/j.ahj.2004.09.023, 15990759.
37. Gonseth J, Guallar-Castillion P, Banegas J, Rodriguez-Artelajo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: A systematic review of published papers. European Heart Journal 2004, 25:1570-1595. 10.1016/j.ehj.2004.04.022, 15351157.
38. Xu H, Platt RW, Luo ZC, Wei S, Fraser WD. Exploring heterogeneity in meta-analyses: needs, resources and challenges. Paediatric and Perinatal Epidemiology 2008, 22:18-28. 10.1111/j.1365-3016.2007.00908.x, 18237348.
39. Ioannidis JPA, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. British Medical Journal 2007, 335:914-916. 10.1136/bmj.39343.408449.80, 2048840, 17974687.
40. Hatala R, Keitz S, Wyer P, Guyatt G, . the Evidence-based Medicine Teaching Tips Working Group Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. Canadian Medical Association Journal 2005, 172:661-665. 10.1503/cmaj.1031920, 550638, 15738493, the Evidence-based Medicine Teaching Tips Working Group.
41. Smith V, Devane D, Begley C, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Medical Research Methodology 2011, 11:15. 10.1186/1471-2288-11-15, 3039637, 21291558.
42. Moher D, Liberati A, Tetzlaff J, Altman DG, . the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. British Medical Journal 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551, the PRISMA Group.
43. Clark AM, Thompson DR. What type of heart failure program is best? Wrong question, wrong assumption. European Jounal of Heart Failure 2010, 12:1271-1273.
44. Clark AM, Savard LA, Thompson DR. What is the strength of evidence for heart failure disease management programs?. Journal of the American College of Cardiology 2009, 54:397-401. 10.1016/j.jacc.2009.04.051, 19628113.
45. Clark AM, Thompson DR. The future of heart failure disease management programs. Lancet 2008, 372:784-786. 10.1016/S0140-6736(08)61317-3, 18774405.
46. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews?. British Medical Journal 2008, 336:1472-1474. 10.1136/bmj.39590.732037.47, 2440840, 18583680.
47. Konstam MA, Konstam V. Heart failure disease management: A sustainable energy source for the health care engine. Journal of the American College of Cardiology 2010, 56:379-381. 10.1016/j.jacc.2010.04.021, 20650359.
48. Shepperd S, Lewin S, Straus S, Clarke M, Eccles MP, Fitzpatrick R, Wong G, Sheikh A. Can we systematically review studies that evaluate complex interventions?. PLoS Medicine 2009, 6(8):e1000086. 10.1371/journal.pmed.1000086, 2717209, 19668360.
49. Boutron I, Moher M, Altman DG, Schulz KF, Ravaud P, . the CONSORT Group Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Annals of Internal Medicine 2008, 148:295-309. the CONSORT Group.
50. Fanelli D. Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data. PLoS ONE 2010, 5:e10271. 10.1371/journal.pone.0010271, 2858206, 20422014.
51. Etter JF, Stapleton J. Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals. Journal of Clinical Epidemiology 2009, 62:831-837. 10.1016/j.jclinepi.2008.09.015, 19128941.
52. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. Journal of the American Medical Association 2010, 303:2058-2064. 10.1001/jama.2010.651, 20501928.
53. Pawson R. Evidence-based policy: A realist perspective 2006, London: Sage.
54. Seow H, Phillips CO, Rich MW, Spertus JA, Krumholz HM, Lynn J. Isolation of health services research from practice and policy: The example of chronic heart failure management. Journal of the American Geriatrics Society 2006, 54:535-540. 10.1111/j.1532-5415.2005.00638.x, 16551325.
55. Tu K, Gong Y, Austin P, Jaakimanian L, Tu J. Canadian Cardiovascular Outcomes Research Team. An overview of the types of physicians treating acute cardiac conditions in Canada. Canadian Journal of Cardiology 2004, 20:282-291.
56. Ezekowitz J, van Walraven C, F M, Armstrong P, Kaul P. Impact of specialist follow-up in outpatients with congestive heart failure. Canadian Medical Association Journal 2005, 172:189-194. 10.1503/cmaj.1032017, 543981, 15655239.